The resistance of human glioma cells to Fas/APO-1 antibody-mediated apoptosis was mainly associated with a low level of Fas/APO-1 expression, but cytokines IFN-γ and TNF-α enhanced the sensitivity to Fas/APO-1-mediated killing. The gene discussed is FAS; the disease is central nervous system cancer.